Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells
Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Liver fibrosis is a consequence of chronic liver disease, causing morbidity and mortality. Interleukin-33 (IL-33) is a critical mediator of inflammation, which may be involved in the development of liver fibrosis. Here, we investigated the role of IL-33 in human patients and experimental bile-duct ligation (BDL)-induced fibrosis in mice. We report...
Alternative Titles
Full title
Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6052839
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6052839
Other Identifiers
ISSN
1672-7681
E-ISSN
2042-0226
DOI
10.1038/cmi.2016.63
